Marubeni Corp.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Income-Applicable-To-Common-Shares" stands at 514.76 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Marubeni Corp.'s first quarter result of 154.40 Billion JPY for the item "Net Income Applicable To Common Shares" represents an increase of 98.49 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Marubeni Corp.'s first quarter result of 154.40 Billion JPY for the item "Net Income Applicable To Common Shares" represents an increase of 8.27 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Marubeni Corp.'s first quarter result of 514.76 Billion JPY for the item "Net Income Applicable To Common Shares" represents an increase of 2.35 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 42.03 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 42.03 Billion Japanese Yens.
The 3 year change is 3.92 Billion Japanese Yens.
The 5 year change is 723.17 Billion Japanese Yens.
The 10 year change is 407.21 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Berkshire Hathaway Inc - Net Income Applicable To Common Shares | 1,088,030,244,864.00 |
![]() | Blackstone Group Inc - Net Income Applicable To Common Shares | 186,696,990,720.00 |
![]() | BlackRock Inc - Net Income Applicable To Common Shares | 166,346,604,544.00 |
![]() | KKR & Co LP - Net Income Applicable To Common Shares | 119,832,821,760.00 |
![]() | BioPharma Credit PLC - Net Income Applicable To Common Shares | 101,856,345,600.00 |